Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Change in Accured Expenses (2018 - 2025)

Arcturus Therapeutics Holdings' Change in Accured Expenses history spans 8 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 32.09% year-over-year to $4.5 million; the TTM value through Dec 2025 reached -$15.3 million, down 357.33%, while the annual FY2025 figure was -$15.3 million, 357.33% down from the prior year.
  • Change in Accured Expenses reached $4.5 million in Q4 2025 per ARCT's latest filing, up from -$5.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.6 million in Q2 2021 to a low of -$9.4 million in Q4 2021.
  • Average Change in Accured Expenses over 5 years is $182800.0, with a median of -$81000.0 recorded in 2023.
  • Peak YoY movement for Change in Accured Expenses: soared 465.08% in 2021, then tumbled 2174.66% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$9.4 million in 2021, then skyrocketed by 178.73% to $7.4 million in 2022, then tumbled by 61.65% to $2.8 million in 2023, then surged by 130.15% to $6.6 million in 2024, then tumbled by 32.09% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Change in Accured Expenses are $4.5 million (Q4 2025), -$5.4 million (Q3 2025), and -$6.1 million (Q2 2025).